Sharma Sudivya, Tiwari Shashank, Sharma Kailash, Nair Nita
Department of Anaesthesia Critical Care and Pain, Tata Memorial Hospital, Homi Bhabha National Institute, 400012 Mumbai, India.
Banaras Hindu University, Varanasi, India.
Indian J Surg Oncol. 2021 Mar;12(1):158-163. doi: 10.1007/s13193-020-01269-2. Epub 2021 Jan 4.
This study was conducted to evaluate the efficacy of pectoral nerve block for post-operative analgesia in breast surgery patients. This double blinded, randomized controlled trial was conducted after Clinical Trials Registry-India registration. Sixty ASA grade I-II female patients undergoing unilateral modified radical mastectomy under general anesthesia, were recruited pre-operatively in two groups. PECS group ( = 29) was given ipsilateral pectoral nerve block I & II while the CONTROL group ( = 29) directly proceeded to surgery. Our primary outcome was comparison of immediate post-operative pain scores at rest and movement. The secondary outcomes were post-operative pain scores at 2, 4, 6, 12, 18, and 24 h, total intraoperative fentanyl consumption, time to rescue analgesia, post-operative nausea vomiting, and complications, if any. Categorical data was analyzed by using the chi-squared test or Fishers Exact test. Comparison of pain scores was analyzed by using the Independent sample test. The immediate post-operative pain scores in two groups were comparable. The pain scores were also comparable at 4, 6, 12, and 24 h; but statistically significantly lower in PECS group at 2 and 18 h. The total intraoperative fentanyl consumption was also reduced in PECS group ( = 0.009). Only 9 patients in PECS group (796.5 min) as compared to 22 patients in CONTROL group (387.7 min) required rescue analgesia ( = 0.001). Pectoral nerve block benefits patients undergoing mastectomy by achieving similar post-operative pain scores with decreased consumption of intraoperative and post-operative opioids. Registration. Clinical Trials Registry of India, (CTRI/2017/04/008289). ctri.nic.in.
本研究旨在评估胸神经阻滞对乳腺癌手术患者术后镇痛的效果。这项双盲随机对照试验在印度临床试验注册中心注册后开展。60例接受全身麻醉下单侧改良根治性乳房切除术的ASA I-II级女性患者在术前被分为两组。胸神经阻滞组(n = 29)接受同侧胸神经I和II阻滞,而对照组(n = 29)直接进行手术。我们的主要结局是比较术后静息和活动时的即时疼痛评分。次要结局包括术后2、4、6、12、18和24小时的疼痛评分、术中芬太尼总消耗量、补救镇痛时间、术后恶心呕吐及并发症(如有)。分类数据采用卡方检验或Fisher精确检验进行分析。疼痛评分比较采用独立样本t检验。两组术后即时疼痛评分相当。在4、6、12和24小时时疼痛评分也相当;但在2小时和18小时时胸神经阻滞组的疼痛评分在统计学上显著更低。胸神经阻滞组术中芬太尼总消耗量也有所减少(P = 0.009)。与对照组的22例患者(387.7分钟)相比,胸神经阻滞组仅9例患者(796.5分钟)需要补救镇痛(P = 0.001)。胸神经阻滞通过实现相似的术后疼痛评分并减少术中和术后阿片类药物的消耗,使乳房切除术患者受益。注册信息:印度临床试验注册中心,(CTRI/2017/04/008289)。ctri.nic.in。